Recently, some genome-wide association studies (GWAS) have found the association between AD and key microglial genes, including CD33 and TREM2 genes involved in innate immunity [15–18], suggesting immune system-mediated actions contribute to or drive AD pathogenesis. The gene discussed is CD33; the disease is Alzheimer disease.